lyophilized powder is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-04. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈3,108 Da | Synthetic 28-residue peptide |
| Amino acid count | 28 | N-terminal serine carries an acetyl group |
| Appearance | White to off-white powder | Lyophilized solid |
| Water solubility | Freely soluble | Dissolves in aqueous buffer |
| Common synonyms | Thymalfasin; Tα1 | Thymalfasin is the international nonproprietary name |
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Identity and purity are usually checked by reverse-phase high-performance liquid chromatography, which separates the intact chain from truncated products, together with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion and amino acid analysis add sequence-level evidence. Release testing also covers water content, residual solvents, and counter-ions, all of which influence measured mass and stability. Related-peptide limits are commonly expressed as a percentage of total peak area, with individual unspecified impurities held below a lower threshold.
The lyophilized peptide is a white to off-white powder that dissolves freely in water and in aqueous buffers near neutral pH. Because the molecule carries a net negative charge under physiological conditions, saline and phosphate solutions are the usual vehicles, while strongly acidic media are avoided. Stock solutions are commonly divided into small aliquots so that repeated freezing and thawing can be limited, since cycling may encourage aggregation. Solubility in organic solvents is poor and those solvents are seldom used as primary diluents.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
=== Market === The market for PFAS was estimated to be US$28 billion in 2023. The majority are produced by 12 companies: 3M, AGC Inc., Archroma, Arkema, BASF, Bayer, Chemours, Daikin, Honeywell, Merck Group, Shandong Dongyue Chemical, and Solvay. Sales of PFAS, which cost approximately $20 per kilogram, generated a total industry profit of $4 billion per year on 16% profit margins in 2023.
== Protein content == The protein content of whole hemp seeds can vary between 20 and 25% depending on variety and environmental factors. Processing methods such as dehulling or oil fraction removal can increase the protein concentration in products like dehulled seed or hemp seed meal to over 50%. Hemp seeds are comparable with soybeans in terms of nutrition. They are high in protein, low in carbohydrates, and rich in dietary fiber and unsaturated fatty acids. After the oil is extracted from the hemp seeds, the residual mass is a protein-rich material useful for food processing. The protein in hemp seeds is made up of the two highly digestible globular types of proteins, edestin (60–80%) and 2S albumin, with edestin also being rich in the essential amino acids.
{\displaystyle -{\frac {\mathrm {d} p}{\mathrm {d} x}}={\frac {8\mu Q}{\pi R^{4}}}={\frac {8\mu Q_{2}p_{2}}{\pi pR^{4}}}\quad \Rightarrow \quad -p{\frac {\mathrm {d} p}{\mathrm {d} x}}={\frac {8\mu Q_{2}p_{2}}{\pi R^{4}}}.}
Barrel-ageing (US: Barrel aging) is the process of ageing beer in wooden barrels to achieve a variety of effects in the final product. Sour beers such as lambics are fully fermented in wood, while other beers are aged in barrels which were previously used for maturing wines or spirits. In 2016 "Craft Beer and Brewing" wrote: "Barrel-aged beers are so trendy that nearly every taphouse and beer store has a section of them.
=== Blo–Bou === Katharine Burr Blodgett (1898–1979), American surface chemist and physicist and inventor of nonreflective glass Suzanne Blum (born 1978), American chemist developing single-molecule and single-particle fluorescence microscopy Katharine Blunt (1876–1954), American chemist and nutritionist focusing on home economics, food chemistry and nutrition Herman Boerhaave (1668–1738) Dutch chemist, botanist, Christian humanist & physician, first to isolate urea from urine Kristie Boering (born 1963), American chemist and planetary scientist studying atmospheric chemistry and mass transport in the extraterrestrial atmosphere Alexei Bogdanov (born 1935), Soviet and Russian biochemist and molecular biologist known for fundamental contributions to ribosome structure and function, nucleic acid-protein interactions, and protein biosynthesis mechanisms. Olga Bogdanova (1896–1982), Soviet chemist who specialized in organic catalysis Dale L. Boger (born 1953), American chemist working on natural product synthesis, synthetic methodology, medicinal chemistry, and combinatorial chemistry Paul Emile Lecoq de Boisbaudran (1838–1912), French chemist who discovered gallium, samarium and dysprosium Jan Boldingh (1915–2003), Dutch chemist known for new analytic techniques such as gas-chromatography and others Alexander Borodin (1833–1887), Russian chemist and composer.
Sources: en.wikipedia.org
== Literature == Emanuel Gil-Av, Present status of enantiomeric analysis by gas chromatography, J. Mol. Evol. 6 (1975) 131–144. Nelu Grinberg: Emanuel Gil-Av (1916–1996): A man with a legacy, In: Chirality, 1998;10(5):372. Volker Schurig: In Memoriam – Emanuel Gil-Av. In: Journal of High Resolution Chromatography 19 (1996) 462. Volker Schurig: On the Centenary of Emanuel Gil-Av, Former Professor of the Weizmann Institute of Science and Pioneer of Enantioselective Chromatography, Isr. J. Chem. 56 (2016) 890–906.
CK1δ is involved in different developmental pathways, among them Wingless (Wnt)-, Hedgehog (Hh)-, and Hippo (Hpo)-pathways. In the Wnt pathway, CK1δ can phosphorylate different factors of the pathway, among them Dishevelled (Dvl), Axin, APC, and β-catenin. CK1δ also negatively influences the stability of β-catenin, after its phosphorylation on Ser-45, which permits GSK3β-mediated further phosphorylations and subsequent degradation.
== Career == She began working as a biochemistry and nutrition professor at the University of San Martín de Porres in 2001. Many of her research projects have been financed by CONCYTEC. She was a member of the Advisory Committee of the School of Food Science from 2011 to 2013, and served as an undergraduate and postgraduate professor at UNMSM. Additionally, she taught at University of San Martín de Porres from 1998 to 2013 and at Cayetano Heredia University School of Pharmacy and Biochemistry from 2014 to 2015. From 2012 to 2016, Muñoz's investigative research and projects, were subsidized by her alma mater, UNMSM. As part of her academic growth, she has participated in congresses by a variety of institutions, including the Latin American Society of Nutrition, Chemical Society of Peru and Peruvian Society of Nutrition, of which she is a member. She was previously the President of the Chemical Society of Peru Magazine and has served as President of the Consultative Committee Hipolito Unanue Foundation since 2023. She was the Rector of San Ignacio de Loyola University (USIL) from 2022 to 2023. Previously, she was the Dean of Health Sciences at USIL from 2016 to 2017. Since 2023 she has been the Vice Rector of Research at USIL. She published her first book, Estudio químico-bromatológico del fruto Carica monoica desf., through Editorial Académica Española in 2012. She was a co-author of the 2020 book Nutrición e Inmunidad: salud en los tiempos de COVID-19.
Steven Eugene Wilson (born 1951) is an American ophthalmologist and professor at Cleveland Clinic, where he is a surgeon and directs corneal research. He has also received honors for several published historical fiction novels. His research has focused on corneal cellular responses to injury and surgery, with his most-cited work being about keratocyte apoptosis, as well as cellular and molecular interactions involved in homeostasis, wound healing, and diseases of the cornea. He holds two United States patents related to corneal healing. He previously served as a professor and chair of the Department of Ophthalmology at the University of Washington in Seattle from 1998 to 2003, and was named Grace E. Hill Endowed Chair in Vision Research.
Sources: en.wikipedia.org
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.